Skip to main content

Advertisement

Table 4 Pharmaceuticals characteristics of studies involving drug therapy (n = 35)

From: Academic pediatric clinical research: factors associated with study implementation duration

Pharmaceutical characteristics Studies involving drug therapy (n = 35)
Inclusion of children under 6 years old 26 (74)
Randomized study 26 (74)
Duration of treatment, days 60 [5;365]
Blinded investigator 16 (46)
Blinded patient 17 (49)
Control group  
Standard treatment 10 (29)
Placebo 13 (37)
No control group 12 (34)
At least a drug of the study not approved in pediatric population 10 (33)
Age-appropriate formulation  
Appropriate 26 (74)
Intermediate at least for one drug of the study 3 (9)
Inappropriate at least for one drug of the study 6 (17)
Route of administration  
Enterally at least for one drug of the study 19 (54)
Parenterally 16 (46)
  1. Values shown are median [25th percentile; 75th percentile] and number (percentage)